Search
+
    SEARCHED FOR:

    IPOS 2023

    Swiggy announces $65 million ESOP programme for employees ahead of IPO

    As part of the scheme, Swiggy employees across all levels and functions will have the opportunity to receive up to $65 million in liquidity for their ESOPs. This marks Swiggy's fifth liquidity event since 2018 and the third consecutive event following those in July 2022 and 2023. This positions Swiggy as one of the few start-ups consistently providing wealth-creation opportunities for its employees.

    Risk factors that are often overlooked in IPO papers

    Governance risks in red herring prospectuses include promoters in similar businesses, high related party transactions such as Cello World’s 53% FY23 revenue, regulatory investigations, and Emcure Pharma’s US antitrust cases. Allied Blenders reports statutory dues delays with interest payments, and missing corporate filings suggest documentation gaps. Investors should carefully review these aspects.

    Shark tank fame Namita Thapar shares an emotional Mirza Ghalib shayari post Emcure IPO's robust listing

    The robust listing met expectations, reflecting the company's long-term potential. Analysts recommend that investors maintain their positions for promising future returns.

    In equity's Indian summer, IPOs and investors make hay in 2024

    The IPO market in 2024 has seen strong investor interest with 38 companies listing at an average gain of 25%. While some stocks like Jyoti CNC Automation and Exicom Tele-Systems have surged 100-300%, others are trading below offer price. Major IPOs from Bharti Hexacom and Aadhar Housing Finance have performed well.

    Bhavish Aggarwal compares Ola's upcoming IPO with that of Maruti's 20 years ago

    Ola founder Bhavish Aggarwal elaborated on the process involved. "We filed the final observations. There's still a bunch of process steps to go through over the next few weeks. And as we go through them, we are keen to get onto the markets, as soon as we get them, but you won't give a date from data because, there's a SEBI process that you have to follow."

    Emcure Pharmaceuticals IPO share allotment likely on Monday. Here's how you can check the status.
    • Emcure Pharmaceuticals IPO booked nearly 68 times so far on Day 3. Check GMP and other details

      Emcure Pharmaceuticals IPO sees strong demand with oversubscription. Anchor investors include top names. Company engaged in global pharmaceutical products. Revenue growth and plans for debt payment outlined. Book-running lead managers identified.

      Namita Thapar-backed Emcure Pharma IPO opens for subscription. Should you bid?

      Emcure Pharma IPO: Emcure Pharmaceuticals IPO, with marquee investors like Goldman Sachs, offers a fresh equity issuance and OFS. Namita Thapar to earn Rs 127 crore through the stake sale. The company targets debt repayment and global expansion.

      Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other details

      Emcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business improvements and revenue growth potential in the global pharmaceutical market, supporting the company's expansion strategies.

      Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details

      Emcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on July 5. The categories reserved for NII and retail investors were subscribed the most at 13 times and 3.43 times, respectively.

      Nephro Care shares list at 90% premium on NSE SME platform

      Nephro Care made a strong market debut on NSE SME platform with a 90% premium. The IPO garnered massive investor interest, oversubscribed by over 700 times. The company aims to establish a 100-bed multispeciality hospital in Kolkata using proceeds from the IPO. Nephro Care, led by Dr. Pratim Sengupta, focuses on comprehensive medical services for renal patients.

      Shark tank fame Namita Thapar to rake in Rs 127 crore through Emcure Pharma IPO

      Shark Tank's Namita Thapar, who is part of Emcure Pharmaceuticals' promoter group, is set to earn approximately Rs 127 crore through the upcoming IPO. Thapar, who acquired shares in Emcure at an average price of Rs 3.44 each, will sell around 12.68 lakh shares through the OFS component of the IPO. With the upper price band set at Rs 1,008 per share, the stake sale is expected to yield about Rs 127 crore.

      Ambey Laboratories opens today: Check issue size, price band, GMP & other details

      Ambey Laboratories’ SME IPO, aiming to raise Rs 44.68 crore by July 8, offers shares at Rs 65-68 in lots of 2,000. With Rs 100 crore revenue and Rs 6.02 crore profit, it's set to list on NSE SME.

      Vraj Iron and Steel makes a healthy debut. What should investors do now?

      Vraj Iron and Steel has a proven track record of consistent profitability over the past three years, demonstrating its ability to generate healthy returns. However, analysts said investors should acknowledge certain risks, such as the concentration of manufacturing facilities in a single region and the lack of long-term customer contracts.

      Vraj Iron and Steel GMP: Will there be a listing pop at the bourses tomorrow?

      Vraj Iron and Steel's shares trade at a 67 rupee premium in the unlisted market, suggesting a potential 32% listing gain. However, grey market premiums are volatile and may not be accurate. The strong IPO subscription of 126.36 times reflects investor confidence in the company's prospects.

      Bansal Wire IPO to open for subscription on Wednesday. Here's what GMP indicates

      The company aims to raise approximately Rs 745 crore at the upper end of its price band. Investors can bid for a minimum of 58 shares per lot, with the option to bid in multiples of this lot size. Prior to the IPO subscription, the company's shares were trading at a premium of Rs 65 in the unlisted market.

      Namita Thapar's Emcure Pharmaceuticals IPO opens on Wednesday. What GMP signals ahead of subscription

      Emcure Pharmaceuticals' IPO opens for subscription on July 3rd with shares trading at a Rs 265 premium in the unlisted market. The IPO includes fresh equity shares worth Rs 800 crore and an Offer For Sale (OFS) of 1.14 crore shares. Priced at Rs 960-1,008 per share, investors can bid for 14 shares per lot. The company targets to raise Rs 1,952 crore at the upper price range.

      Sebi approves IPOs of FirstCry, Unicommerce and Gala

      Sebi approves IPO plans for FirstCry, Unicommerce, and Gala. FirstCry proposes to utilise the net proceeds up to Rs 1816 crore from the offer towards funding the expenditure for setting up new modern stores under the 'BabyHug' brand, setting up a warehouse in India, expenditure for lease payments for the existing identified modern stores owned and operated by the company, in India. Gala Precision Engineering had filed its IPO papers with Sebi on February 14, 2024. The IPO consists of a fresh issue of equity shares up to 25.58 lakh and an offer for sale up to 6.16 lakh by the promoter group and individual selling shareholders.

      Bansal Wire IPO opens Wednesday: Here are 10 things to know about the public offer

      The IPO of Bansal Wire is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 745 crore through this public offering. This IPO consists entirely of a fresh equity sale of 2.91 crore shares, with no OFS component involved. According to market analysts, Bansal Wire currently commands a GMP of Rs 65 in the unlisted market.

      Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issue

      Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 1,952 crore through the public offer. Market analysts indicate that the current GMP of the pharma company stands at Rs 260 in the unlisted market.

      Vraj Iron and Steel IPO share allotment likely today. Here's how you can check status

      Vraj Iron and Steel IPO, oversubscribed 100 times, plans to utilize proceeds for Bilaspur plant expansion. The company's shares trade at a premium in the unlisted market. Product offerings include TMT bars and Dolochar. Loan from HDFC Bank to be repaid with IPO funds, with internal accruals contributing to the balance amount.

      Multibagger debut! Shivalic Power Control shares list at 211% premium over IPO price

      The IPO, which was completely a fresh equity sale of 64.32 lakh shares, was subscribed over 250 times at close, driven by strong interest from retail and non-institutional investors.

      Vraj Iron and Steel IPO subscribed nearly 40 times so far on last day. Check GMP and other details

      Analysts advised investors to subscribe to the Vraj Iron and Steel IPO as the company's well-established and strategically located manufacturing facilities, coupled with a focus on value-added products and ongoing expansion plans, position it for future growth. The company's shares are trading with a premium of Rs 90 in the unlisted market,

      Nephro Care IPO opens today: Check issue size, price band, GMP and other details

      Invest in the Nephro Care IPO in Kolkata to support healthcare initiatives and gain potential returns through shares.

      Allied Blenders IPO: Check subscription on last day, GMP and other details

      The IPO of Allied Blenders and Distillers was subscribed 23.49 times on its third and final day. NIIs show strong interest with 32 times subscription, followed by retail investors at 4.42 times. The QIB portion of the issue was booked 50 times. The IPO combines a Rs 1,000 crore fresh equity sale and OFS of 1.77 crore shares, allowing promoters Bina Kishore Chhabria and Resham Chhabria Jeetendra to reduce their stakes.

      Shivalic Power Control IPO allotment today; check status, GMP, listing date and other details

      In the unlisted market, the company's shares are trading at a premium of Rs 175. If the trend continues, the company is expected to debut with gains of 175% on July 1. Investors can check the status of Shivalic Power Control IPO allotment by logging in to the official website of the registrar, which is Skyline Financial Services in this case.

      Allied Blenders and Distillers IPO subscribed 1.51 times on Day 2. Check subscription, GMP and other details

      ABDL's IPO involves a fresh equity sale of Rs 1,000 crore and an offer for sale (OFS) of 1.77 crore shares by promoters Bina Kishore Chhabria and Resham Chhabria Jeetendra. Funds raised will repay borrowings and fund corporate needs. The company's shares are trading with a GMP of Rs 87.

      Sylvan Plyboard IPO opens: Check issue size, price band, GMP, and other details

      Sylvan Plyboard IPO aims to raise about Rs 28.05 crore through the SME issue and list the shares on the NSE SME platform. The company's shares were trading with a GMP of 15 in the unlisted market.

      Shivalic Power Control IPO opens today: Check issue size, price band, GMP and other details

      Shivalic Power Control IPO aims to raise about Rs 64 crore through the SME IPO and list the shares on the NSE SME platform. The company is offering shares at Rs 95-100 apiece, and investors can bid for 1,200 shares in a lot.

      Load More
    The Economic Times
    BACK TO TOP